if (document.domain != 'www.netvibes.com') { document.write( '\n\t\n\n\n\n\n\n\n\n\n
\n\t
\n\n\t\t\n\n\n\t\t

\n\t\t\tPredictive Biosciences\n\t\t\thttp://www.predictivebiosci.com/\n\t\t

\n\t\t

\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t

\n\t
\n\t
\n\t\t
\n\n\t\t\t

Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare...More»

\n\t\t\t

Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare investors, experienced entrepreneurs, and internationally-renowned scientists in the areas of tumor growth, tumor angiogenesis, and cancer markers. Predictive Biosciences possesses an extensive IP portfolio \u2013 including 18 issued and pending US patents \u2013 and deep in-house expertise in proteomics, diagnostics, oncology, and tumor biomarkers.

Leveraging its portfolio of patented biomarkers and clinical algorithms, Predictive Biosciences is pioneering novel diagnostic assays for informed cancer management\u2122. Predictive seeks to significantly improve care and reduce healthcare costs for cancer patients by personalizing diagnostic workups and clinical interventions.«Less

\n\n\t\t\t
\n\t\t\t\t
Overview
\n\t\t\t\t

Location: \tLexington, MA, United States\n

\n\t\t\t\t

Industry: Medical Devices & Equipment

\n\t\t\t\t

Tags:\n\t\t\t\tpredictive,\n\t\t\t\tHealthcare,\n\t\t\t\tmolecular diagnostics,\n\t\t\t\tcancer management,\n\t\t\t\tdiagnostic assays,\n\t\t\t\tbiomarkers,\n\t\t\t\tcancer,\n\t\t\t\tassays\n\t\t\t\t

\n\t\t\t
\n\n\t\t\t
\n\t\t\t\t
Financials
\n\t\t\t\t

Latest Funding: Series B - $21.75M (10/2008)

\n\t\t\t\t

Investors:\n\t\t\t\t\t\n\t\tNew Enterprise Associates,\n\t\t\t\t\t\n\t\tKaiser Permanente Ventures\n\t\t\t\t

\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
Market
\n\t\t\t\t

Competitors:\n\t\t\t\t\t\tExagen Diagnostics,\n\t\t\t\t\t\tLabNow,\n\t\t\t\t\t\tAllegro Diagnostics\n\t\t\t\t

\n\n\t\t\t\t

Related Companies:\n\t\t\t\t\tExagen Diagnostics,\n\t\t\t\t\tVentiRx,\n\t\t\t\t\tSword Diagnostics,\n\t\t\t\t\tMicroFluidic Systems,\n\t\t\t\t\tCelator Pharmaceuticals,\n\t\t\t\t\tChromoTrax,\n\t\t\t\t\tVarian Medical Systems,\n\t\t\t\t\tArresto Biosciences,\n\t\t\t\t\tPrecision Therapeutics,\n\t\t\t\t\tAscenta Therapeutics\n\t\t\t\t

\n\t\t\t
\n\n\t\t\t
\n\t\t\t\t
Recent News
\n\t\t\t\t

\n\t\t\t\t\tFeb 2, 2010\n\t\t\t\t\tDiagnostic Industry Veteran Kim Blickenstaff Joins Predictive Biosciences\u2019 Board of Directors\n\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\tOct 21, 2008\n\t\t\t\t\tVertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News\n\t\t\t\t

\n\t\t\t
\n\n\t\t
\n\t
\n\t

\n\t\tPredictive Biosciences Company Profile powered by VentureBeat Profiles.\n\t

\n
\n' ); if (typeof tradevibes_post == "function") { tradevibes_post(); } }